Every OB-GYN practice manager keeps a mental list of the authorizations that quietly died. The maternal-fetal-medicine ultrasound the payer bounced for "insufficient documentation" the week your biller was out. The fetal MRI denied on a coding technicality that nobody had 45 minutes to untangle. The genetic-carrier-screening auth that expired in a portal you only check when a claim comes back. None of these were unwinnable. They were unfiled. And that distinction is the single most expensive thing happening in your revenue cycle right now.
The numbers make the case brutally clear. Across Medicare Advantage, more than 80% of appealed prior authorization denials are overturned in the provider's favor. Yet only about 11.5% of denials are ever appealed at all. Read those two figures together and a prior authorization denial appeal service stops looking like a nice-to-have and starts looking like the recovery of revenue you already earned. The denials are not the core problem. The appeals gap is.
The 11.5% appeal rate is a staffing failure, not a clinical one
It is tempting to assume that the 88.5% of denials nobody appeals are the weak cases - the ones where the payer was right and an appeal would waste everyone's time. The overturn data says the opposite. If more than four out of five appealed denials get reversed, and practices only bother appealing the ones they think they can win, then the pool of never-appealed denials is full of cases that would also have been overturned. Practices are not filtering out losers. They are filtering out work.
Walk the actual workflow in a two-provider OB-GYN office and the reason becomes obvious. A denial arrives - sometimes as a portal flag, sometimes as a mailed letter three weeks after the fact. Someone has to notice it, read the denial reason, pull the ordering provider's clinical note, find the relevant ACOG or SMFM medical-necessity criteria, write a coherent argument tying the note to the criteria, attach the supporting imaging or lab, route it to the correct payer appeal address, and calendar the deadline for escalation. That is 30 to 90 minutes per denial, done correctly. Your front desk is also answering phones, checking in patients, and running same-day eligibility. The appeal loses that fight every single time.
So the denial gets triaged the way overwhelmed staff triage everything: the loud, deadline-driven work wins, and the appeal that could wait until "later" waits until the payer's 30-to-60-day window closes on its own. The write-off is not a decision anyone made out loud. It is what happens when nobody has the hour.
Which OB-GYN authorizations are actually worth chasing
Not every denied auth carries the same recoverable dollars, and a practice with limited appeal hours should not spread them evenly. The highest-yield targets in OB-GYN share one trait: clean, defensible medical-necessity documentation, which is exactly what overturns denials.
- MFM and detailed fetal ultrasounds (76811, 76812). These are ordered against specific indications - advanced maternal age, abnormal screening, prior anomaly - that map directly to published criteria. A denial for "not medically necessary" usually falls apart the moment the indication and the ordering note are put in front of a reviewer.
- Fetal MRI and advanced imaging. High-dollar, frequently denied on coding or documentation technicalities rather than true non-coverage. The four-figure value makes even a 60-minute appeal worth it, and the clinical justification is typically well documented.
- Genetic and carrier screening. Denials here often stem from a missing supporting diagnosis code or an eligibility mismatch that a clean resubmission with the right documentation fixes.
- Non-obstetric procedures - hysteroscopy, endometrial ablation, certain laparoscopies. Payers lean hard on conservative-treatment-first criteria; when the chart shows the failed conservative course, the overturn is straightforward.
The pattern across all four: the denial reason is procedural or documentary, not a hard coverage exclusion. Those are the winnable 80%. A denied cosmetic-adjacent service or a genuinely non-covered benefit is a different animal - but those are the minority, and mistaking the whole pile for that minority is how practices talk themselves out of filing.
How the appeals gap cascades into lost revenue
The damage compounds in a way that is easy to miss from inside the daily churn. Here is how one denial becomes a permanent write-off.
flowchart TD
A[Prior auth denied] --> B{Does anyone notice<br/>before deadline}
B -->|No| C[Appeal window closes]
B -->|Yes| D{Free staff hour<br/>to build appeal}
D -->|No| E[Deferred to later]
E --> C
D -->|Yes| F[Appeal filed with<br/>note and criteria]
F --> G[80 percent overturned]
G --> H[Revenue recovered]
C --> I[Silent write-off]
I --> J[Service delayed<br/>or patient billed]
J --> K[Bad debt or<br/>patient leaves]Every branch that ends in a write-off started with a resource shortage, not a clinical judgment. And the write-off is rarely the end of the cost. When an auth for an MFM ultrasound dies, the study is often delayed while staff and patient sort out coverage, which pushes a time-sensitive scan later into a pregnancy where the timing actually matters. Or the practice performs the service anyway and eats the cost, or bills the patient for a four-figure balance they were never warned about - which becomes bad debt, an angry review, and sometimes a lost patient. One unfiled appeal radiates into scheduling friction, clinical-timing risk, and patient trust, not just a line item.
Turning turnaround time into a reason to automate the appeal
The other half of the prior auth problem is speed, and it feeds directly into the appeals gap. Slow authorization turnaround means denials surface late, appeal windows are already half-spent by the time anyone looks, and the deferred-to-later pile grows. Prior authorization turnaround time reduction and appeal recovery are the same workflow viewed from two ends: the faster you detect and act on a denial, the more of the 80% you actually capture before deadlines expire.
This is where an AI layer changes the economics. CallSphere's platform is built to remove exactly the manual hours that kill appeals. Its voice AI can call payers to check authorization and denial status without a staff member sitting on hold, so denials surface the day they happen instead of three weeks later. When a denial lands, the system flags it, pulls the ordering provider's note, matches the denial reason to the right medical-necessity criteria, and drafts the appeal packet - turning a 60-minute assembly job into a review-and-send. It tracks each payer's appeal deadline so nothing closes silently, and it routes the submission through the correct channel. You can see the full workflow on the /features page, and the /pricing page lays out how the cost compares to the revenue a single overturned four-figure MFM appeal recovers.
The point is not to replace clinical judgment on which appeals to file. It is to make filing cheap enough that "not worth the hour" stops being the default answer. When the marginal cost of an appeal drops from 60 minutes of scarce staff time to a few minutes of review, the 11.5% appeal rate has nowhere to go but up - and every point of increase is overturnable revenue that used to evaporate.
Reducing eligibility denials so fewer appeals ever start
The cheapest appeal is the one you never have to file. A meaningful share of what shows up as prior auth trouble is really an upstream eligibility problem - a patient whose plan changed, a benefit that needed auth nobody flagged, a diagnosis code that did not support the requested service. Catching those before the service reduces the denial pile that feeds the appeals backlog in the first place.
Real-time eligibility and benefit checks at scheduling do two things at once. They confirm whether the specific OB-GYN service actually needs authorization for that plan, so you request it early instead of discovering the requirement in a denial. And they surface the deductible, coverage limits, and diagnosis requirements that, left unverified, turn into the "insufficient documentation" and "not medically necessary" denials you would otherwise be appealing weeks later. Pairing front-end verification with back-end appeal recovery attacks the problem from both directions: fewer denials created, and a far higher share of the denials that do occur actually filed and overturned. That combination is how a two-provider practice stops leaking recoverable revenue without hiring a dedicated authorization specialist it cannot justify.
What to do with the denials sitting in your queue right now
Start with a count, not a system. Pull every prior auth denial from the last 90 days and sort by dollar value. You will almost certainly find that a handful of MFM ultrasounds, fetal imaging studies, and non-obstetric procedures account for most of the recoverable money, and that most of them were denied on documentation or coding grounds rather than hard exclusion. Those are your first appeals - the ones where the 80% overturn rate is on your side and the note to support it already exists in the chart.
Then look at why they went unfiled. If the answer is "nobody had the time," that is a workflow problem with a workflow fix, and it is worth solving before the next quarter's denials join the pile. The revenue is already earned. The service was already rendered or the study already ordered. What stands between your practice and that money is not the payer's judgment - four out of five times the payer's judgment reverses. It is whether the appeal ever gets written. Close that gap and the denials stop being losses and go back to being what they always were: recoverable revenue waiting on a piece of paper nobody had the hour to file.